Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 998

1.

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.

Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, Gamble C, McLeod C, Walley T, Dickson R.

Health Technol Assess. 2008 Apr;12(12):iii-iv, xi-xii, 1-154. Review.

2.

The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.

Hockenhull JC, Dwan KM, Smith GW, Gamble CL, Boland A, Walley TJ, Dickson RC.

Crit Care Med. 2009 Feb;37(2):702-12. doi: 10.1097/CCM.0b013e3181958915. Review.

PMID:
19114884
3.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

4.

Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.

Schumm K, Lam TB.

Neurourol Urodyn. 2008;27(8):738-46. doi: 10.1002/nau.20645. Review.

PMID:
18951451
5.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

6.

Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.

Niël-Weise BS, Stijnen T, van den Broek PJ.

J Hosp Infect. 2008 Jun;69(2):114-23. doi: 10.1016/j.jhin.2008.02.020. Epub 2008 Apr 25. Review.

PMID:
18439717
7.

Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Niël-Weise BS, Stijnen T, van den Broek PJ.

Intensive Care Med. 2007 Dec;33(12):2058-68. Epub 2007 Oct 17. Review.

PMID:
17940746
8.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

9.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

10.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

11.

A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D.

Health Technol Assess. 2006 Jun;10(20):iii-iv, ix-113. Review.

12.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

13.

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.

14.

A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.

Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.

Health Technol Assess. 2008 Jan;12(1):iii-iv, xi-xii, 1-147. Review.

15.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

16.

The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.

Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS.

Health Technol Assess. 2007;11(21):iii-iv, ix-xi, 1-93. Review.

17.
18.

Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling.

Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, Song F.

Health Technol Assess. 2007 Oct;11(38):iii-iv, ix-66. Review.

19.

Drug-eluting stents: a systematic review and economic evaluation.

Hill RA, Boland A, Dickson R, Dündar Y, Haycox A, McLeod C, Mujica Mota R, Walley T, Bagust A.

Health Technol Assess. 2007 Nov;11(46):iii, xi-221. Review.

20.

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S.

Cochrane Database Syst Rev. 2013 Jun 6;6:CD007878. doi: 10.1002/14651858.CD007878.pub2. Review.

PMID:
23740696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk